Putnam Global Health Care Y holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Putnam Global Health Care Fund Class Y PHSYX
- NAV / 1-Day Return $74.10 / +0.34 %
- Fund Size $1.5B
- Adjusted Expense Ratio 0.790%
- Net Expense Ratio 0.790%
- Fee Level: Distribution Below Average
- Share Class Type Institutional
- Morningstar Category Health
- Equity Style Box (Funds) Large Blend
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.36%
- Turnover Ratio 67%
Morningstar’s Analysis PHSYX
Will PHSYX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 59.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 12.63 | 195M | Healthcare |
Johnson & Johnson | 9.44 | 145M | Healthcare |
AbbVie Inc | 6.74 | 104M | Healthcare |
UnitedHealth Group Inc | 6.03 | 93M | Healthcare |
Merck & Co Inc | 5.75 | 89M | Healthcare |
Novartis AG Registered Shares | 4.91 | 76M | Healthcare |
Thermo Fisher Scientific Inc | 4.05 | 62M | Healthcare |
AstraZeneca PLC | 3.84 | 59M | Healthcare |
Intuitive Surgical Inc | 3.39 | 52M | Healthcare |
Vertex Pharmaceuticals Inc | 3.06 | 47M | Healthcare |